Viewing nowMicatan Tablet 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
SS Pharm Co., Ltd.

MFDS item code 201003097 · Notified 2010.04.27 · Insurance code 652602880
Treatment of essential hypertension; prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication is used to treat essential hypertension. Additionally, it helps lower the risk of major cardiovascular disease occurrence in high-risk patients aged 55 and older with a history of coronary artery disease, peripheral artery disease, stroke or transient ischemic attack, or organ damage due to diabetes. It reduces the risk of myocardial infarction, stroke, and death due to cardiovascular diseases. Therefore, it improves the management of hypertension while preventing cardiovascular diseases.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm, especially to the fetus and newborn, during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals with hypersensitivity to this medication, pregnant or breastfeeding women, patients with severe liver impairment or biliary obstruction, patients with hereditary angioedema, and certain renal impairment patients. Caution is advised for the elderly, patients with hyperkalemia, mild to moderate liver impairment, valvular heart disease, ischemic heart disease, gastrointestinal disease, renovascular hypertension, and patients with severe renal impairment. During treatment with this medication, various adverse reactions may occur, and symptoms such as hypotension, changes in renal function, hyperkalemia, angioedema, liver dysfunction, interstitial lung disease, and rhabdomyolysis should be closely monitored. Patients with decreased kidney function or kidney transplant recipients should regularly check serum potassium and creatinine levels, and those with reduced blood volume or sodium are at risk for hypotension and should correct their status before taking this medication. Caution is needed when taking this medication with other antihypertensive agents as it may enhance the antihypertensive effect, and interactions may occur when used with certain drugs, so consultation with healthcare professionals is essential. Pregnant women or those planning to become pregnant should not take this medication, and breastfeeding mothers should also avoid it. The safety and efficacy of this medication for children under 18 years have not been established; therefore, it is not recommended. Elderly patients are at risk of stroke due to excessive blood pressure reduction, so their condition should be monitored closely during treatment. In case of overdose, symptoms such as hypotension, dizziness, acute renal failure may occur, and emergency medical treatment should be sought immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.
White or whitish oval tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
SS Pharm Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.